Furthermore, deletion of SPOP dramatically promoted the expression of BRMS1 and decreased the level of OPN and uPA targeted and inhibited by BRMS1 in BC cells, suggesting that SPOP can also exert an oncogenic role in BC tumorigenesis and progression (Fig. 6) [125]. Here, PLAU is linked to breast cancer.